138
Murat A, Migliavacca E, Gorlia T et al (2008a) Stem cell–related “Self-Renewal” signature and
high epidermal growth factor receptor expression associated with resistance to concomitant
chemoradiotherapy in glioblastoma. J Clin Oncol 26(18):3015–3024
Murat A, Migliavacca E, Gorlia T et al (2008b) Stem cell-related “self-renewal” signature and
high epidermal growth factor receptor expression associated with resistance to concomitant
chemoradiotherapy in glioblastoma. J Clin Oncol 26(18):3015–3024
Nakada M, Nambu E, Furuyama N et al (2013) Integrin [alpha]3 is overexpressed in glioma stem-
like cells and promotes invasion. Br J Cancer 108(12):2516–2524
Nath B, Szabo G (2012) Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.
Hepatology 55(2):622–633
Nguyen LV, Vanner R, Dirks P, Eaves CJ (2012) Cancer stem cells: an evolving concept. Nat Rev
Cancer 12(2):133–143
Nhan T, Burgess A, Lilge L, Hynynen K (2014) Modeling localized delivery of Doxorubicin to
the brain following focused ultrasound enhanced blood-brain barrier permeability. Phys Med
Biol 59(20):5987–6004
Nishide K, Nakatani Y, Kiyonari H, Kondo T (2009) Glioblastoma formation from cell population
depleted of Prominin1-expressing cells. PLoS One 4(8):e6869
Ogden AT, Waziri AE, Lochhead RA et al (2008) Identification of A2B5+CD133- tumor-initiating
cells in adult human gliomas. Neurosurgery 62(2):505–514. discussion 514-505
Paez-Gonzalez P, Asrican B, Rodriguez E, Kuo CT (2014) Identification of distinct ChAT+ neurons
and activity-dependent control of postnatal SVZ neurogenesis. Nat Neurosci 17(7):934–942
Palmer TD, Willhoite AR, Gage FH (2000) Vascular niche for adult hippocampal neurogenesis.
J Comp Neurol 425(4):479–494
Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx
2(1):3–14
Patel AP, Tirosh I, Trombetta JJ et al (2014) Single-cell RNA-seq highlights intratumoral hetero-
geneity in primary glioblastoma. Science 344(6190):1396–1401
Persano L, Pistollato F, Rampazzo E et al (2012) BMP2 sensitizes glioblastoma stem-like cells
to Temozolomide by affecting HIF-1[alpha] stability and MGMT expression. Cell Death Dis
e412:3
Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood–brain barrier: structural com-
ponents and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol
1(3):223–236
Pistollato F, Chen H-L, Rood BR et al (2009) Hypoxia and HIF1α repress the differentiative effects
of BMPs in high-grade glioma. Stem Cells 27(1):7–17
Pistollato F, Abbadi S, Rampazzo E et al (2010) Intratumoral hypoxic gradient drives stem cells
distribution and MGMT expression in glioblastoma. Stem Cells 28(5):851–862
Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C et al (2006) Pigment epithelium-
derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 9(3):331–339
Reiss Y, Machein MR, Plate KH (2005) The role of angiopoietins during angiogenesis in gliomas.
Brain Pathol 15(4):311–317
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells.
Nature 414(6859):105–111
Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differen-
tiation of glioblastoma stem-like cells. Nature 468(7325):824–828
Riquelme PA, Drapeau E, Doetsch F (2008) Brain micro-ecologies: neural stem cell niches in the
adult mammalian brain. Philos Trans R Soc Lond Ser B Biol Sci 363(1489):123–137
Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) ‘Pseudopalisading’ necrosis in glioblastoma:
a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.
J Neuropathol Exp Neurol 65(6):529
Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K (2015)
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differenti-
ated non-GSCs and GSCs. Genes Diseases 2(2):152–163
A. Sattiraju et al.